SlideShare a Scribd company logo
1 of 15
Paperwork, Paperwork

How to Format Your EPA Submission
        Presented by Karen E. Warkentien
        Compliance Services International




                 CSMA Workshop
Contents of Application Package
 EPA Administrative Forms
 Cover Letter/Transmittal Document
 Draft Label
 Tolerance Petition (if necessary)
 Studies (if necessary)



                CSMA Workshop
EPA Form 8570-What?
 EPA Forms
 – Application for Pesticide Registration/
   Amendment (EPA Form 8570-1)
 – Confidential Statement of Formula (EPA Form
   8570-4)
 – Notice of Supplemental Distribution of a
   Registered Pesticide Product (EPA Form
   8570-5)

                  CSMA Workshop
EPA Form 8570-What?
 EPA Forms (cont.)
 – Formulator’s Exemption Statement (EPA Form
   8570-27)
 – Certification with Respect to Citation of Data
   (EPA Form 8570-34)
 – Data Matrix (EPA Form 8570-35)



                   CSMA Workshop
Which Forms Do I Need?
 Distributing a Registered Product
 – Supplemental Distribution Form
    • Signed by the primary registrant and the distributor
    • Once mailed to EPA, the registration is effective
    • No other documents required




                      CSMA Workshop
Which Forms Do I Need?
 Formulating from a Registered Source
 – Application Form
    • Basic product and contact information
    • Substantially-similar (“me-too”) fast track review
       – Allows for faster review of new products that are identical
         or very similar in composition to an already registered
         product.
 – Confidential Statement of Formula
    • Lists ingredients in the product in weight percent
    • Proprietary “recipe” for production
                        CSMA Workshop
Which Forms Do I Need?
 Formulating from a Registered Source (cont.)
 – Formulator’s Exemption Form
    • Lists registered source material
    • Exempts registrant from conducting/citing generic
      active ingredient testing
 – Citation of Data Form/Data Matrix
    • Required when data are submitted and/or cited
       – Need to offer to pay compensation when citing data
         generated by others
       – Matrix lists studies registration application relies on
                         CSMA Workshop
Which Forms Do I Need?
 Formulating from an Unregistered Source
 – Application Form
 – Confidential Statement of Formula
 – Certification with Respect to Citation of Data
    • Methods of Support
       – Cite-All Method
       – Selective Method
       – Cite-All Option under the Selective Method


                       CSMA Workshop
Which Forms Do I Need?
 Formulating from an Unregistered Source
 – Data Matrix
    • List all guideline requirements and data submitted
      and/or cited
    • Two versions
       – Agency Copy
           » All information about the cited studies is provided
       – Public Copy
           » Guideline reference, study name, and MRID number
             are blacked out
                       CSMA Workshop
What’s in a Letter?
 Cover Letter
  – Accompanies package and directs submission
    to the proper product manager (if known)
  – Identifies the type of submission
  – Provides company contact information
  – Can be combined with transmittal document



                   CSMA Workshop
What’s in a Letter?
 Transmittal Document
  – Required when data are submitted
  – Identifies the studies submitted
     • Volume number
     • Guideline reference
     • Study title/Laboratory/Author/Date
  – Can be incorporated into the cover letter


                      CSMA Workshop
Labeling
 Draft label
 – Guidance Documents
    • Regulations in 40 CFR § 156.10
    • Label Review Manual
    • PR Notices
 – Provides use directions for the product
 – Includes information about human health,
   environmental effects, product composition
 – Five (5) copies required
                     CSMA Workshop
Tolerance Petitions
 When Required
  – If proposed use results in residues in/on food
    commodities and no tolerance or exemption has
    been established
 What’s Required
  – Tolerance petition per 40 CFR § 180.7
  – Data to support tolerance/exemption
  – $$$$$
                    CSMA Workshop
Data Submission and PRN 86-5
 PR Notice 86-5
 – Established formatting guidelines for all studies
 – Requires basic information about the following
    •   Data submitter/Laboratory/Guideline
    •   Confidentiality of data
    •   Good Laboratory Practice (GLP) compliance
    •   Flagging of toxic effects (for some toxicology
        studies)
 – Three (3) copies of each submitted study
                        CSMA Workshop
Data Submission and PRN 86-5
 PR Notice 86-5 (cont.)
 – EPA front-end review
    • Assigns MRID numbers to studies that comply
       – Master Record Identification numbers
    • Rejects noncompliant studies
       –   Not assigned MRID numbers
       –   Notice of noncompliance states deficiencies
       –   Rejected studies returned to registrant for reformatting
       –   Must be resubmitted with new transmittal document


                          CSMA Workshop

More Related Content

What's hot

What's hot (11)

Presentation: eSubmissions in Australia - Part 2
Presentation: eSubmissions in Australia - Part 2Presentation: eSubmissions in Australia - Part 2
Presentation: eSubmissions in Australia - Part 2
 
FDA News Presentation
FDA News PresentationFDA News Presentation
FDA News Presentation
 
How sap can help pharmaceutical companies
How sap can help pharmaceutical companiesHow sap can help pharmaceutical companies
How sap can help pharmaceutical companies
 
SAP Consulting Services in Pharmaceuticals | Apprisia
SAP Consulting Services in Pharmaceuticals | ApprisiaSAP Consulting Services in Pharmaceuticals | Apprisia
SAP Consulting Services in Pharmaceuticals | Apprisia
 
Oracle Clinical Overview_Katalyst HLS
Oracle Clinical Overview_Katalyst HLSOracle Clinical Overview_Katalyst HLS
Oracle Clinical Overview_Katalyst HLS
 
Risk Based Approach CSV Training_Katalyst HLS
Risk Based Approach CSV Training_Katalyst HLSRisk Based Approach CSV Training_Katalyst HLS
Risk Based Approach CSV Training_Katalyst HLS
 
Clinical Data Management Plan_Katalyst HLS
Clinical Data Management Plan_Katalyst HLSClinical Data Management Plan_Katalyst HLS
Clinical Data Management Plan_Katalyst HLS
 
Data Integrity
Data IntegrityData Integrity
Data Integrity
 
eTMF ppt
eTMF ppteTMF ppt
eTMF ppt
 
Data integrity in pharmaceutical industry a brief overview
Data integrity in pharmaceutical industry a brief overviewData integrity in pharmaceutical industry a brief overview
Data integrity in pharmaceutical industry a brief overview
 
Laboratory Information Systems LIS Software
Laboratory Information Systems LIS SoftwareLaboratory Information Systems LIS Software
Laboratory Information Systems LIS Software
 

Similar to 20000426 Adminstrative Documents For Epa Registration

Making the Move to an Enterprise Clinical Trial Management System
Making the Move to an Enterprise Clinical Trial Management SystemMaking the Move to an Enterprise Clinical Trial Management System
Making the Move to an Enterprise Clinical Trial Management System
Perficient
 
Automating Phase One Clinical Trials
Automating Phase One Clinical TrialsAutomating Phase One Clinical Trials
Automating Phase One Clinical Trials
Perficient
 
A Step-by-Step Guide for Method Validation
A Step-by-Step Guide for Method ValidationA Step-by-Step Guide for Method Validation
A Step-by-Step Guide for Method Validation
complianceonline123
 
Guidelines to Audit Validation Packages_RGA
Guidelines to Audit Validation Packages_RGAGuidelines to Audit Validation Packages_RGA
Guidelines to Audit Validation Packages_RGA
Rosnelma García
 
How Can Clinical Affairs Play The Role Of
How Can Clinical Affairs Play The Role OfHow Can Clinical Affairs Play The Role Of
How Can Clinical Affairs Play The Role Of
raaz80_in
 
Proficiency Testing (PT) – a tool to improve laboratory performance - Brian B...
Proficiency Testing (PT) – a tool to improve laboratory performance - Brian B...Proficiency Testing (PT) – a tool to improve laboratory performance - Brian B...
Proficiency Testing (PT) – a tool to improve laboratory performance - Brian B...
Mara International
 
Practical application of the tmf reference model
Practical application of the tmf reference modelPractical application of the tmf reference model
Practical application of the tmf reference model
Subhash Chandra
 

Similar to 20000426 Adminstrative Documents For Epa Registration (20)

Making the Move to an Enterprise Clinical Trial Management System
Making the Move to an Enterprise Clinical Trial Management SystemMaking the Move to an Enterprise Clinical Trial Management System
Making the Move to an Enterprise Clinical Trial Management System
 
MES systems
MES systemsMES systems
MES systems
 
Unit 02 chapter 05 documentation systems documents and record keeping
Unit 02 chapter 05   documentation systems documents and record keepingUnit 02 chapter 05   documentation systems documents and record keeping
Unit 02 chapter 05 documentation systems documents and record keeping
 
Automating Phase One Clinical Trials
Automating Phase One Clinical TrialsAutomating Phase One Clinical Trials
Automating Phase One Clinical Trials
 
A Step-by-Step Guide for Method Validation
A Step-by-Step Guide for Method ValidationA Step-by-Step Guide for Method Validation
A Step-by-Step Guide for Method Validation
 
Guidelines to Audit Validation Packages_RGA
Guidelines to Audit Validation Packages_RGAGuidelines to Audit Validation Packages_RGA
Guidelines to Audit Validation Packages_RGA
 
Quality Course 1
Quality Course 1Quality Course 1
Quality Course 1
 
Quality system gmp
Quality system gmpQuality system gmp
Quality system gmp
 
How Can Clinical Affairs Play The Role Of
How Can Clinical Affairs Play The Role OfHow Can Clinical Affairs Play The Role Of
How Can Clinical Affairs Play The Role Of
 
Handling Third Party Vendor Data_Katalyst HLS
Handling Third Party Vendor Data_Katalyst HLSHandling Third Party Vendor Data_Katalyst HLS
Handling Third Party Vendor Data_Katalyst HLS
 
Presentation: Overcoming the stress of non-prescription medicine application ...
Presentation: Overcoming the stress of non-prescription medicine application ...Presentation: Overcoming the stress of non-prescription medicine application ...
Presentation: Overcoming the stress of non-prescription medicine application ...
 
Proficiency Testing (PT) – a tool to improve laboratory performance - Brian B...
Proficiency Testing (PT) – a tool to improve laboratory performance - Brian B...Proficiency Testing (PT) – a tool to improve laboratory performance - Brian B...
Proficiency Testing (PT) – a tool to improve laboratory performance - Brian B...
 
P rocess validation 1
P rocess validation 1P rocess validation 1
P rocess validation 1
 
qmpfull.ppt
qmpfull.pptqmpfull.ppt
qmpfull.ppt
 
xx QMP QMS QA documents full.ppt
xx QMP QMS QA documents full.pptxx QMP QMS QA documents full.ppt
xx QMP QMS QA documents full.ppt
 
qmpfull.ppt
qmpfull.pptqmpfull.ppt
qmpfull.ppt
 
Sponsor Information and Training day Session B1 - Medical Devices: Conformity...
Sponsor Information and Training day Session B1 - Medical Devices: Conformity...Sponsor Information and Training day Session B1 - Medical Devices: Conformity...
Sponsor Information and Training day Session B1 - Medical Devices: Conformity...
 
Submitting electronic Drug Master Files (DMF) and Active Substance Master Fil...
Submitting electronic Drug Master Files (DMF) and Active Substance Master Fil...Submitting electronic Drug Master Files (DMF) and Active Substance Master Fil...
Submitting electronic Drug Master Files (DMF) and Active Substance Master Fil...
 
The ABCs of Clinical Trial Management Systems
The ABCs of Clinical Trial Management SystemsThe ABCs of Clinical Trial Management Systems
The ABCs of Clinical Trial Management Systems
 
Practical application of the tmf reference model
Practical application of the tmf reference modelPractical application of the tmf reference model
Practical application of the tmf reference model
 

More from Karen Warkentien (7)

TSCA Compliance Chart
TSCA Compliance ChartTSCA Compliance Chart
TSCA Compliance Chart
 
20071001 TSCA-FIFRA Presentation
20071001 TSCA-FIFRA Presentation20071001 TSCA-FIFRA Presentation
20071001 TSCA-FIFRA Presentation
 
20011200 Cpda Festf Update
20011200 Cpda Festf Update20011200 Cpda Festf Update
20011200 Cpda Festf Update
 
20031028 Cpda Festf Update
20031028 Cpda Festf Update20031028 Cpda Festf Update
20031028 Cpda Festf Update
 
20040129 Cpda Festf Update
20040129 Cpda Festf Update20040129 Cpda Festf Update
20040129 Cpda Festf Update
 
20050503 40 Cfr Part 158 Proposed Rule Presentation
20050503 40 Cfr Part 158 Proposed Rule Presentation20050503 40 Cfr Part 158 Proposed Rule Presentation
20050503 40 Cfr Part 158 Proposed Rule Presentation
 
20051116 40 Cfr Part 158 For Cpda Registration 201
20051116 40 Cfr Part 158 For Cpda Registration 20120051116 40 Cfr Part 158 For Cpda Registration 201
20051116 40 Cfr Part 158 For Cpda Registration 201
 

20000426 Adminstrative Documents For Epa Registration

  • 1. Paperwork, Paperwork How to Format Your EPA Submission Presented by Karen E. Warkentien Compliance Services International CSMA Workshop
  • 2. Contents of Application Package EPA Administrative Forms Cover Letter/Transmittal Document Draft Label Tolerance Petition (if necessary) Studies (if necessary) CSMA Workshop
  • 3. EPA Form 8570-What? EPA Forms – Application for Pesticide Registration/ Amendment (EPA Form 8570-1) – Confidential Statement of Formula (EPA Form 8570-4) – Notice of Supplemental Distribution of a Registered Pesticide Product (EPA Form 8570-5) CSMA Workshop
  • 4. EPA Form 8570-What? EPA Forms (cont.) – Formulator’s Exemption Statement (EPA Form 8570-27) – Certification with Respect to Citation of Data (EPA Form 8570-34) – Data Matrix (EPA Form 8570-35) CSMA Workshop
  • 5. Which Forms Do I Need? Distributing a Registered Product – Supplemental Distribution Form • Signed by the primary registrant and the distributor • Once mailed to EPA, the registration is effective • No other documents required CSMA Workshop
  • 6. Which Forms Do I Need? Formulating from a Registered Source – Application Form • Basic product and contact information • Substantially-similar (“me-too”) fast track review – Allows for faster review of new products that are identical or very similar in composition to an already registered product. – Confidential Statement of Formula • Lists ingredients in the product in weight percent • Proprietary “recipe” for production CSMA Workshop
  • 7. Which Forms Do I Need? Formulating from a Registered Source (cont.) – Formulator’s Exemption Form • Lists registered source material • Exempts registrant from conducting/citing generic active ingredient testing – Citation of Data Form/Data Matrix • Required when data are submitted and/or cited – Need to offer to pay compensation when citing data generated by others – Matrix lists studies registration application relies on CSMA Workshop
  • 8. Which Forms Do I Need? Formulating from an Unregistered Source – Application Form – Confidential Statement of Formula – Certification with Respect to Citation of Data • Methods of Support – Cite-All Method – Selective Method – Cite-All Option under the Selective Method CSMA Workshop
  • 9. Which Forms Do I Need? Formulating from an Unregistered Source – Data Matrix • List all guideline requirements and data submitted and/or cited • Two versions – Agency Copy » All information about the cited studies is provided – Public Copy » Guideline reference, study name, and MRID number are blacked out CSMA Workshop
  • 10. What’s in a Letter? Cover Letter – Accompanies package and directs submission to the proper product manager (if known) – Identifies the type of submission – Provides company contact information – Can be combined with transmittal document CSMA Workshop
  • 11. What’s in a Letter? Transmittal Document – Required when data are submitted – Identifies the studies submitted • Volume number • Guideline reference • Study title/Laboratory/Author/Date – Can be incorporated into the cover letter CSMA Workshop
  • 12. Labeling Draft label – Guidance Documents • Regulations in 40 CFR § 156.10 • Label Review Manual • PR Notices – Provides use directions for the product – Includes information about human health, environmental effects, product composition – Five (5) copies required CSMA Workshop
  • 13. Tolerance Petitions When Required – If proposed use results in residues in/on food commodities and no tolerance or exemption has been established What’s Required – Tolerance petition per 40 CFR § 180.7 – Data to support tolerance/exemption – $$$$$ CSMA Workshop
  • 14. Data Submission and PRN 86-5 PR Notice 86-5 – Established formatting guidelines for all studies – Requires basic information about the following • Data submitter/Laboratory/Guideline • Confidentiality of data • Good Laboratory Practice (GLP) compliance • Flagging of toxic effects (for some toxicology studies) – Three (3) copies of each submitted study CSMA Workshop
  • 15. Data Submission and PRN 86-5 PR Notice 86-5 (cont.) – EPA front-end review • Assigns MRID numbers to studies that comply – Master Record Identification numbers • Rejects noncompliant studies – Not assigned MRID numbers – Notice of noncompliance states deficiencies – Rejected studies returned to registrant for reformatting – Must be resubmitted with new transmittal document CSMA Workshop